Your search returned 530 results.

Results
	481.	Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial. [electronic resource] by Popat, Rakesh Brown, Sarah R Flanagan, Louise Hall, Andrew Gregory, Walter Kishore, Bhuvan Streetly, Matthew Oakervee, Heather Yong, Kwee Cook, Gordon Low, Eric Cavenagh, Jamie Producer: 20180116 In: The Lancet. Haematology vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	482.	The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia. [electronic resource] by Baker, Adele Gregory, Gareth P Verbrugge, Inge Kats, Lev Hilton, Joshua J Vidacs, Eva Lee, Erwin M Lock, Richard B Zuber, Johannes Shortt, Jake Johnstone, Ricky W Producer: 20160729 In: Cancer research vol. 76 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	483.	Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors. [electronic resource] by Yun, Mi Ran Lim, Sun Min Kim, Seon-Kyu Choi, Hun Mi Pyo, Kyoung-Ho Kim, Seong Keun Lee, Ji Min Lee, You Won Choi, Jae Woo Kim, Hye Ryun Hong, Min Hee Haam, Keeok Huh, Nanhyung Kim, Jong-Hwan Kim, Yong Sung Shim, Hyo Sup Soo, Ross Andrew Shih, Jin-Yuan Yang, James Chih-Hsin Kim, Mirang Cho, Byoung Chul Producer: 20190730 In: Cancer research vol. 78 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	484.	Acquired vorinostat resistance shows partial cross-resistance to 'second-generation' HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities. [electronic resource] by Dedes, Konstantin J Dedes, Ioannis Imesch, Patrick von Bueren, André O Fink, Daniel Fedier, André Producer: 20090715 In: Anti-cancer drugs vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	485.	Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors. [electronic resource] by Bots, Michael Verbrugge, Inge Martin, Benjamin P Salmon, Jessica M Ghisi, Margherita Baker, Adele Stanley, Kym Shortt, Jake Ossenkoppele, Gert J Zuber, Johannes Rappaport, Amy R Atadja, Peter Lowe, Scott W Johnstone, Ricky W Producer: 20140506 In: Blood vol. 123 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	486.	Combinatorial antitumor effect of HDAC and the PI3K-Akt-mTOR pathway inhibition in a Pten defecient model of prostate cancer. [electronic resource] by Ellis, Leigh Ku, Sheng Yu Ramakrishnan, Swathi Lasorsa, Elena Azabdaftari, Gizzou Godoy, Alejandro Pili, Roberto Producer: 20141112 In: Oncotarget vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	487.	Panobinostat enhances cytarabine and daunorubicin sensitivities in AML cells through suppressing the expression of BRCA1, CHK1, and Rad51. [electronic resource] by Xie, Chengzhi Drenberg, Christina Edwards, Holly Caldwell, J Timothy Chen, Wei Inaba, Hiroto Xu, Xuelian Buck, Steven A Taub, Jeffrey W Baker, Sharyn D Ge, Yubin Producer: 20140818 In: PloS one vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	488.	Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion. [electronic resource] by Yang, Yonghua Rao, Rehka Shen, Jie Tang, Yun Fiskus, Warren Nechtman, John Atadja, Peter Bhalla, Kapil Producer: 20080818 In: Cancer research vol. 68 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	489.	Treatment with panobinostat induces glucose-regulated protein 78 acetylation and endoplasmic reticulum stress in breast cancer cells. [electronic resource] by Rao, Rekha Nalluri, Srilatha Kolhe, Ravindra Yang, Yonghua Fiskus, Warren Chen, Jianguang Ha, Kyungsoo Buckley, Kathleen M Balusu, Ramesh Coothankandaswamy, Veena Joshi, Atul Atadja, Peter Bhalla, Kapil N Producer: 20100707 In: Molecular cancer therapeutics vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	490.	Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat). [electronic resource] by Kubo, Makoto Kanaya, Noriko Petrossian, Karineh Ye, Jingjing Warden, Charles Liu, Zheng Nishimura, Reiki Osako, Tomofumi Okido, Masayuki Shimada, Kazuo Takahashi, Masato Chu, Peiguo Yuan, Yate-Ching Chen, Shiuan Producer: 20130527 In: Breast cancer research and treatment vol. 137 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	491.	LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/STAT3/Akt pathway. [electronic resource] by Song, Xuan Wang, Jiabei Zheng, Tongsen Song, Ruipeng Liang, Yingjian Bhatta, Nishant Yin, Dalong Pan, Shangha Liu, Jiaren Jiang, Hongchi Liu, Lianxin Producer: 20140708 In: Molecular cancer vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	492.	The HDAC inhibitor LBH589 induces ERK-dependent prometaphase arrest in prostate cancer via HDAC6 inactivation and down-regulation. [electronic resource] by Chuang, Mei-Jen Wu, Sheng-Tang Tang, Shou-Hung Lai, Xiang-Me Lai, Hsiao-Chu Hsu, Kai-Hsiang Sun, Kuang-Hui Sun, Guang-Huan Chang, Sun-Yran Yu, Dah-Shyong Hsiao, Pei-Wen Huang, Shih-Ming Cha, Tai-Lung Producer: 20140408 In: PloS one vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	493.	Activation of p21 by HDAC inhibitors requires acetylation of H2A.Z. [electronic resource] by Bellucci, Luca Dalvai, Mathieu Kocanova, Silvia Moutahir, Fatima Bystricky, Kerstin Producer: 20130724 In: PloS one vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	494.	LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway. [electronic resource] by Hasegawa, H Yamada, Y Tsukasaki, K Mori, N Tsuruda, K Sasaki, D Usui, T Osaka, A Atogami, S Ishikawa, C Machijima, Y Sawada, S Hayashi, T Miyazaki, Y Kamihira, S Producer: 20110609 In: Leukemia vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	495.	The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells. [electronic resource] by Berghauser Pont, Lotte M E Kleijn, Anne Kloezeman, Jenneke J van den Bossche, Wouter Kaufmann, Johanna K de Vrij, Jeroen Leenstra, Sieger Dirven, Clemens M F Lamfers, Martine L M Producer: 20160406 In: PloS one vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	496.	HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target. [electronic resource] by Ria, Roberto Catacchio, Ivana Berardi, Simona De Luisi, Annunziata Caivano, Antonella Piccoli, Claudia Ruggieri, Vitalba Frassanito, Maria Antonia Ribatti, Domenico Nico, Beatrice Annese, Tiziana Ruggieri, Simona Guarini, Attilio Minoia, Carla Ditonno, Paolo Angelucci, Emanuele Derudas, Daniele Moschetta, Michele Dammacco, Franco Vacca, Angelo Producer: 20141014 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	497.	Molecular and biologic characterization and drug sensitivity of pan-histone deacetylase inhibitor-resistant acute myeloid leukemia cells. [electronic resource] by Fiskus, Warren Rao, Rekha Fernandez, Pravina Herger, Bryan Yang, Yonghua Chen, Jianguang Kolhe, Ravindra Mandawat, Aditya Wang, Yongchao Joshi, Rajeshree Eaton, Kelly Lee, Pearl Atadja, Peter Peiper, Stephen Bhalla, Kapil Producer: 20081009 In: Blood vol. 112 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	498.	The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6. [electronic resource] by Lu, Kang Fang, Xiao-sheng Feng, Li-li Jiang, Yu-jie Zhou, Xiang-xiang Liu, Xin Li, Pei-pei Chen, Na Ding, Mei Wang, Na Zhang, Jie Wang, Xin Producer: 20150420 In: Cancer letters vol. 359 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	499.	TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets. [electronic resource] by Decaesteker, Bieke Denecker, Geertrui Van Neste, Christophe Dolman, Emmy M Van Loocke, Wouter Gartlgruber, Moritz Nunes, Carolina De Vloed, Fanny Depuydt, Pauline Verboom, Karen Rombaut, Dries Loontiens, Siebe De Wyn, Jolien Kholosy, Waleed M Koopmans, Bianca Essing, Anke H W Herrmann, Carl Dreidax, Daniel Durinck, Kaat Deforce, Dieter Van Nieuwerburgh, Filip Henssen, Anton Versteeg, Rogier Boeva, Valentina Schleiermacher, Gudrun van Nes, Johan Mestdagh, Pieter Vanhauwaert, Suzanne Schulte, Johannes H Westermann, Frank Molenaar, Jan J De Preter, Katleen Speleman, Frank Producer: 20181218 In: Nature communications vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	500.	Histone deacetylase inhibitor panobinostat potentiates the anti-cancer effects of mesenchymal stem cell-based sTRAIL gene therapy against malignant glioma. [electronic resource] by Choi, Seung Ah Lee, Chanhee Kwak, Pil Ae Park, Chul-Kee Wang, Kyu-Chang Phi, Ji Hoon Lee, Ji Yeoun Chong, Sangjoon Kim, Seung-Ki Producer: 20191104 In: Cancer letters vol. 442 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
16
17
18
19
20
21
22
23
24
25
26
27
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 530 results.